PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'CRPV Grenoble, Université Grenoble Alpes, 38043 Grenoble, France.\', \'GSK France, 92500 Rueil-Malmaison, France. Electronic address: sophie.m.muller@gsk.com.\', \'DGS, 75007 Paris, France.\', \'Syndicat des pharmaciens d\'officine, 75009 Paris, France.\', \'Service d\'hypertension artérielle et thérapeutique PCVM, UMR 1027, université de Toulouse 3, CHU de Rangueil, 31059 Toulouse, France.\', \'Collège de médecine générale, 75017 Paris, France.\', \'Le Monde, 75013 Paris, France.\', \'Formation recherche, union francophone patients partenaire, 75012 Paris, France.\', \'LEEM, 75017 ParisFrance.\', \'CRPV, CHRU de Tours, 37044 Tours, France.\', \'Pharmacovigilance et information médicale, AstraZeneca, 92400 Courbevoie, France.\', \'Renaloo, 75013 Paris, France.\', \'CRPV, CEIP-addictovigilance, pharmacologie Aix-Marseille universités, 13005 Marseille, France.\', \'Inserm, BPH, U1219, pharmacoépidémiologie, université Bordeaux, 33000 Bordeaux, France.\', \'Sanofi, 91385 Chilly-Mazarin, France.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0040-5957(22)00005-110.1016/j.therap.2022.01.003
?:doi
?:hasPublicationType
?:journal
  • Therapie
is ?:pmid of
?:pmid
?:pmid
  • 35078658
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.293
?:rankingScore_hIndex
  • 32
is ?:relation_isRelatedTo_publication of
?:title
  • Prevention of risks associated with inappropriate use/unnecessary consumption of medicines.
?:type

Metadata

Anon_0  
expand all